TwinRiver Capital

TwinRiver Capital is an active global impact investment firm focused on advancing positive environmental and societal impact—including health and wellbeing—while delivering financial returns. It mobilizes private, public, and philanthropic capital to scale solutions in energy & environment, health & wellbeing, and inclusive economic growth. Its offerings include public equity funds (such as the TwinRiver Global Impact Fund), private equity investments across asset classes, venture philanthropy products, outcome contracts, and advisory services for institutional investors. The firm's first products launched in fall 2021. No direct clinical results are reported since it is not itself a drug developer.